Related Experiment Video
Updated: Sep 23, 2025

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Helicobacter Pylori Colonization Density is an Important Risk Factor for Eradication Therapy
Hakan Demirci1, Kadir Ozturk2, Alpaslan Tanoglu3
1Department of Gastroenterology, Medical Park Hospital, Istanbul, Turkey. . hakandemircigata@yahoo.com.
Higher Helicobacter pylori (H. pylori) colonization density correlates with decreased eradication therapy success. Severe H. pylori infection may require more potent treatment regimens for effective eradication.
Area of Science:
- Gastroenterology
- Microbiology
- Infectious Diseases
Background:
- Helicobacter pylori (H. pylori) infection treatment efficacy varies despite standardized protocols.
- Risk factors for H. pylori treatment failure are not fully understood.
- Gastric mucosa inflammation and bacterial density are potential factors influencing eradication success.
Purpose of the Study:
- To investigate the association between H. pylori colonization density and the effectiveness of bismuth-containing quadruple therapy.
- To determine if H. pylori bacterial load impacts treatment outcomes.
Main Methods:
- 330 patients with H. pylori positive gastritis underwent histopathological examination.
- H. pylori colonization density was classified as mild, moderate, or severe using the Sydney classification.
- Eradication success was assessed using the 13C-Urea breath test eight weeks post-therapy.
Main Results:
- Successful H. pylori eradication rates decreased with increasing colonization density.
- Per-protocol analysis showed rates of 87.1% (mild), 78.8% (moderate), and 75.5% (severe) (p=0.038).
- Intention-to-treat analysis revealed rates of 81.5% (mild), 73.2% (moderate), and 67.3% (severe) (p=0.017).
Conclusions:
- H. pylori colonization severity may predict eradication therapy effectiveness.
- Patients with severe H. pylori densities may benefit from more potent eradication regimens.
- Pre-treatment assessment of bacterial load could guide therapeutic strategies.
More Related Videos
04:56Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis
Published on: May 16, 2025
03:47Retinal and Choroidal Thickness Changes in Populations with Helicobacter pylori Infection by Swept-Source Optical Coherence Tomography
Published on: November 1, 2024
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...